Streetbeat News

Price Targets

TTD

Stephens & Co. analyst Nicholas Zangler has reiterated an Overweight rating on Trade Desk (NASDAQ:TTD) and maintained an $85 price target.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:13 pm

CDRE

Stephens & Co. analyst Daniel Imbro maintains an Overweight rating on Cadre Holdings (CDRE) and raises the price target from $36 to $40.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:09 pm

HOUS

Stephens & Co. analyst John Campbell has maintained an Equal-Weight rating on Anywhere Real Estate (NYSE:HOUS) and increased the price target from $5.5 to $8.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:07 pm

MLM

Stephens & Co. analyst Trey Grooms maintains an Overweight rating on Martin Marietta Materials (MLM) and raises the price target from $575 to $605.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:02 pm

VNT

Vontier (NYSE:VNT) has received updated analyst ratings over the last three months, with a consensus leaning towards bullish. The average 12-month price target is now $42.75, marking a 6.0% increase from the previous target. Analysts from UBS, Citigroup, and B of A Securities have raised their price targets, reflecting optimism about Vontier's market position despite challenges in revenue growth and high debt levels. Vontier, an industrial technology company, reported $3.2 billion in sales and a net margin of 11.84% for 2022.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:01 pm

BHF

Brighthouse Financial Inc (NASDAQ:BHF) received mixed analyst ratings with a shift towards a more bearish outlook in the past 30 days. The average 12-month price target was adjusted to $50.25, a decrease from the previous $52.50. Analysts from Wells Fargo, Keefe, Bruyette & Woods, and Morgan Stanley have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Despite a remarkable revenue growth of 25.34% as of December 31, 2023, Brighthouse Financial faces challenges in profitability, with a net margin of -67.29% and below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:01 pm

EGP

Analysts have mixed views on EastGroup Props (NYSE:EGP), with recent ratings showing a shift towards a more cautious stance. The average 12-month price target has been raised to $186.8, indicating a positive outlook. Financial performance indicators such as revenue growth, net margin, ROE, and ROA are strong, with the company outperforming industry averages. However, its market capitalization is below industry benchmarks, suggesting room for growth.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:01 pm

PRTA

Prothena Corp (NASDAQ:PRTA) received mixed analyst ratings with a shift towards a more cautious stance in the last quarter. The average 12-month price target was adjusted to $64.5, down from $69.00, indicating a 6.52% decrease. Analysts from firms including RBC Capital, B of A Securities, Cantor Fitzgerald, and Deutsche Bank have updated their ratings and price targets, reflecting changes in market conditions and company performance. Prothena Corp, a biotechnology company, has shown significant revenue growth and strong financial performance, with a revenue growth rate of 5494.33% as of September 30, 2023, and a net margin of 25.81%.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:00 pm

IR

Ingersoll Rand (NYSE:IR) received mixed analyst ratings in the latest quarter with 4 analysts providing their perspectives. The average 12-month price target for IR has been raised to $86.75, indicating a 16.44% increase from the previous target. Analysts from CFRA, UBS, Wells Fargo, and Citigroup have all raised their price targets, reflecting positive sentiment towards the company's market performance and financial health. Ingersoll Rand's revenue growth, net margin, and market capitalization are highlighted as strong points, while its ROE and ROA are below industry averages.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:00 pm

CF

CF Industries Holdings (NYSE:CF) has been analyzed by 4 analysts over the last three months, showing a shift towards a more bullish outlook with 2 somewhat bullish and 2 indifferent ratings recently. The average 12-month price target has been adjusted to $90.0, marking a 6.74% decrease. Financial indicators reveal CF Industries as a strong performer with significant revenue growth, high net margin, and superior ROE and ROA compared to industry averages. The company's focus on low-cost nitrogen production and investment in carbon-free ammonia positions it well for future growth.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:00 pm